Nantahala Capital (QNCX) reports 0% stake in Quince Therapeutics in latest 13G/A
Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, reported a 0% beneficial ownership in Quince Therapeutics, Inc. as of June 30, 2026. This Schedule 13G/A filing indicates that they hold no shares and possess no voting or dispositive power over …